Dr. Alan Hemming, Chief of Transplantation and HPB Surgery and Professor of Surgery at UC San Diego, spoke to Toronto Fellows, Residents and Faculty about “Extending the Limits of Liver Surgery …” earlier this month, at this year’s annual Charbonneau Lecture.

Hemming, a Toronto Fellowship alumnus, is particularly well known for merging technical components of both transplantation and oncologic liver surgery to provide an aggressive approach to liver malignancy.

Alongside Toronto surgeon and Fellowship alumnus Ian McGilvray, he is one of only a few physicians in the North America to perform ex vivo liver surgery.